Back to DE D. E. Shaw & Co., Inc.
RIGL
Showing 0 of 17 quarters
Position history for DED. E. Shaw & Co., Inc.'s holdings in RIGEL PHARMACEUTICALS INC
No. D. E. Shaw exited its RIGL (Rigel Pharmaceuticals) position in Q1 2023. Its Q4 2022 13F listed 3,352,899 shares worth $5M. D. E. Shaw already held RIGL in its Q4 2018 13F, the earliest on record, and held it in 15 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.